Clinical trial
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced…
NCT00251381 · Trial Form Support S.L., Other · Unknown status
Key facts
| NCT number | NCT00251381 |
|---|---|
| Title | Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. |
| Official title | Open Label Randomized Phase II, Multicentre, Pilot Study to Evaluate Safety and Efficacy of the Combination of Cetuximab and Concomitant-Boost Accelerated Radiotherapy Followed or Not by a Complementary Treatment With Cetuximab in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. |
| Lead sponsor | Trial Form Support S.L., Other |
| Collaborators | Merck KGaA, Darmstadt, Germany Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Oropharyngeal Neoplasms |
| Intervention type | Drug |
| Interventions | Cetuximab |
| Enrollment | 90 |
| Start date | Nov 1, 2005 |
| Completion | Nov 1, 2009 |
| First posted | Nov 10, 2005 |
| Last update posted | Oct 26, 2006 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: